Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Week Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Rupatadine 10 and 20 Mg in the Treatment of Chronic Idiopathic Urticaria (CIU): a Phase III Clinical Trial

NCT00199251 is registered in ClinicalTrials.gov with J. Uriach and Company as lead sponsor.

NCT NCT00199251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00199251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Week Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Rupatadine 10 and 20 Mg in the Treatment of Chronic Idiopathic Urticaria (CIU): a Phase III Clinical Trial
Lead sponsor
J. Uriach and Company
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2004
Completion date
June 30, 2005
Enrollment
300
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urticaria